May 4, 2018 06:31 AM EDTUpdated 10:31 AM

In a comeback, Portola scores FDA accelerated approval for once-rejected Andexxa

Somehow staying on the good side of the FDA, Portola $PTLA has scored an elusive regulatory win for their once-rejected drug andexanet alfa. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

In a come­back, Por­to­la scores FDA ac­cel­er­at­ed ap­proval for once-re­ject­ed An­dexxa